The Human Immune Monitoring Core (HIMC) at CUIMC is a hub for comprehensive immune profiling and expert support for advanced immunological research studies.
Jianlong Wang’s devotion to a career to cancer is personally rooted: He lost his 16-year-old brother to leukemia and has since witnessed other family members and friends succumb to the disease.
Adolfo Ferrando has been awarded the William Dameshek Prize for his contributions in advancing acute lymphoblastic leukemia (ALL) and T-cell acute lymphoblastic leukemia (T-ALL) research.
HICCC member Dr. Raul Rabadan has authored a new book, Understanding Coronavirus, to provide readers an accessible overview about the novel virus and COVID-19 pandemic.
Congratulations to Dr. Xuebing Wu, who was just named a 2020 Pew-Stewart Scholar for innovative cancer research by the Pew Charitable Trusts and the Alexander and Margaret Stewart Trust.
OPTIC provides researchers access to a broad range of in vivo imaging technologies that can help advance our understanding of how cancer progresses, and accelerate translational research.
The MCSR at the HICCC provides a wide range of technology platforms and services–from classical cytogenetics and high throughput imaging analyses to sequence-based assessment of DNA damage and repair.